Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Queensland Health
Healthtrust
Boehringer Ingelheim
Farmers Insurance
Federal Trade Commission
McKinsey
Julphar
Express Scripts

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019221

« Back to Dashboard

NDA 019221 describes VASERETIC, which is a drug marketed by Valeant Intl and is included in one NDA. It is available from two suppliers. Additional details are available on the VASERETIC profile page.

The generic ingredient in VASERETIC is enalapril maleate; hydrochlorothiazide. There are twenty-seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the enalapril maleate; hydrochlorothiazide profile page.
Summary for 019221
Tradename:VASERETIC
Applicant:Valeant Intl
Ingredient:enalapril maleate; hydrochlorothiazide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019221
Suppliers and Packaging for NDA: 019221
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221 NDA Valeant Pharmaceuticals North America LLC 0187-0146 N 0187-0146-01
VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221 NDA AUTHORIZED GENERIC Oceanside Pharmaceuticals 68682-146 N 68682-146-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG;25MG
Approval Date:Oct 31, 1986TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG;12.5MG
Approval Date:Jul 12, 1995TE:ABRLD:Yes

Expired US Patents for NDA 019221

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Intl VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-001 Oct 31, 1986 ➤ Sign Up ➤ Sign Up
Valeant Intl VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-003 Jul 12, 1995 ➤ Sign Up ➤ Sign Up
Valeant Intl VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-001 Oct 31, 1986 ➤ Sign Up ➤ Sign Up
Valeant Intl VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-003 Jul 12, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Queensland Health
US Army
Cerilliant
Fuji
Express Scripts
McKinsey
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.